SCHOTT Pharma Aktie
WKN DE: A3ENQ5 / ISIN: DE000A3ENQ51
06.10.2023 08:00:05
|
EQS-News: Bank of America Securities Europe SA: Exercise of the Greenshoe Option and Post-stabilisation Period Announcement
EQS-News: Bank of America Securities Europe SA
/ Key word(s): IPO
6 October 2023
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
SCHOTT Pharma AG & Co. KGaA
Exercise of the Greenshoe Option and Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 27 September 2023, BofA Securities Europe SA (contact: Victor Dumas Vorzet; telephone: +33187701048) hereby gives notice that the Stabilisation Manager named below has fully exercised the over-allotment/greenshoe option (of up to 4,518,438 shares) on 6 October 2023 in respect of 4,518,438 shares at the offer price of EUR 27.00 per share and that the stabilisation period has been concluded early on 6 October 2023. During the stabilisation period, the Stabilisation Manager did not undertake stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/2016/2014), and also as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) in relation to the offer of the following securities, as set out below.
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction. This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
06.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
1742835 06.10.2023 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu SCHOTT Pharmamehr Nachrichten
24.09.25 |
Börsianer in Frankfurt warten auf Impulse: SDAX ohne Schwung (finanzen.at) | |
18.09.25 |
Handel in Frankfurt: SDAX nachmittags im Aufwind (finanzen.at) | |
18.09.25 |
Gewinne in Frankfurt: SDAX beginnt Donnerstagshandel mit Gewinnen (finanzen.at) | |
17.09.25 |
SDAX aktuell: SDAX zum Handelsende mit Gewinnen (finanzen.at) | |
22.08.25 |
Börse Frankfurt in Grün: SDAX zum Start des Freitagshandels mit Gewinnen (finanzen.at) | |
18.08.25 |
EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements (EQS Group) | |
18.08.25 |
EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG (EQS Group) | |
18.08.25 |
EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (EQS Group) |
Analysen zu SCHOTT Pharmamehr Analysen
14.08.25 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
13.08.25 | SCHOTT Pharma Buy | Deutsche Bank AG | |
13.08.25 | SCHOTT Pharma Buy | UBS AG | |
12.08.25 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
12.08.25 | SCHOTT Pharma Buy | UBS AG |
Aktien in diesem Artikel
SCHOTT Pharma | 21,80 | -1,36% |
|